FDA Commissioner Margaret Hamburg Keynote Speaker at 2012 Interchange
"It is sad to realize that we live in a world in which some
criminals are willing to maximize profits by placing poisons
in products like infant formula, toothpaste and
medically necessary drugs."- Commissioner Hamburg
Just announced! Dr. Margaret Hamburg, FDA Commissioner will be the keynote speaker at the 2012 Interchange, September 28th in Washington DC!
We’ve just received official confirmation that Margaret Hamburg, Commissioner of the United States Food and Drug Administration, will give the keynote speech at the 2012 Partnership for Safe Medicines Interchange. We’re very honored to have Commissioner Hamburg speak at the Interchange, and look forward to hearing her offer her expertise on the subject of counterfeit drug crime.
Dr. Hamburg is the 21st commissioner of the Food and Drug Administration. She was confirmed in her post on May 18, 2009. She is only the second woman to be nominated for this position, having served previously as an Assistant Secretary at the US Department of Health and Human Services, and also as Commissioner of the New York City Department of Health.
This will be the second time Commissioner Hamburg has spoken at a Partnership for Safe Medicines Interchange. She first joined us in 2010, where she addressed the problem of counterfeit drugs, “The issue of counterfeit drugs is one of both domestic and international concern. It is shocking to realize that, in some parts of the world, somewhere between 30 and 50 percent of drugs to treat serious diseases are actually counterfeit.”
Fake online drug sellers, gray market distributors, and counterfeit medicines in the U.S.'s safe, secure drug supply chain will be subjects discussed at the 2012 Interchange in Washington DC September 28th. Please join us!
Since her appearance at the 2010 Interchange, the FDA has had to contend with an increasingly globalized drug marketplace. Her continued efforts as commissioner have been to seek greater penalties for drug counterfeiters, and also give the FDA more authority to deal with counterfeit drugs when they discover them.
We hope you will join Commissioner Hamburg, Deputy Director Heddell of the MHRA, Associate Director Dinkins of the ICE Homeland Security Investigations, along with many other experts from medicine, policy, law enforcement, and patient advocacy at our 2012 Interchange in Washington DC. Discounted early registration ends August 15th, so register today!
Want to get a summary of global counterfeit drug news emailed to you every week? Sign up for our email list!
